Equillium (EQ) Earnings Date & Reports

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EQ is expected to report earnings to fall 10.33% to -5 cents per share on August 12

Q2'26

Est.

$-0.05

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.03

Q3'25

Beat

by $0.16

Q2'25

Beat

by $0.03

The last earnings report on May 13 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 461.06K shares outstanding, the current market capitalization sits at 182.09M.

View a ticker or compare two or three

Compare

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EQ

A.I. Advisor